INOVIO PHARMACEUTICALS INC (INO) Institutional Ownership Changes & 13F Activity
INOVIO PHARMACEUTICALS INC (INO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Janus Henderson Group Plc, Ra Capital Management, L.P., Citadel Advisors Llc, Marshall Wace, Llp, and Two Sigma Investments, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Plc | Buy | +10,434,210 | — | 10,434,210 | $12.78M | Q3 2026 | Nov 16, 2026 |
| Ra Capital Management, L.P. | Buy | +7,220,384 | — | 7,220,384 | $8.81M | Q3 2026 | Nov 16, 2026 |
| Citadel Advisors Llc | Buy | +2,884,766 | +1193.2% | 3,126,541 | $3.81M | Q3 2026 | Nov 16, 2026 |
| Two Sigma Investments, Lp | Buy | +1,299,582 | +104.8% | 2,539,360 | $3.10M | Q3 2026 | Nov 16, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +1,116,824 | +82.6% | 2,468,480 | $3.01M | Q3 2026 | Nov 16, 2026 |
| Millennium Management Llc | Sell | -698,144 | -87.7% | 97,963 | $119.52K | Q3 2026 | Nov 16, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +559,137 | — | 559,137 | $682.15K | Q3 2026 | Nov 16, 2026 |
| Eversept Partners, Lp | Buy | +345,841 | +33.4% | 1,381,201 | $1.69M | Q3 2026 | Nov 16, 2026 |
| Bank Of America Corp | Buy | +297,355 | — | 297,355 | $362.77K | Q3 2026 | Nov 16, 2026 |
| Xtx Topco Ltd | Buy | +223,453 | +211.1% | 329,286 | $401.73K | Q3 2026 | Nov 16, 2026 |
| Seven Fleet Capital Management Lp | Buy | +137,100 | — | 137,100 | $167.26K | Q3 2026 | Nov 16, 2026 |
| Gsa Capital Partners Llp | Sell | -113,244 | -42.7% | 151,767 | $185.00 | Q3 2026 | Nov 16, 2026 |
| Graham Capital Management, L.P. | Buy | +93,305 | — | 93,305 | $113.83K | Q3 2026 | Nov 16, 2026 |
| Northern Trust Corp | Buy | +60,866 | +34.9% | 235,260 | $287.02K | Q3 2026 | Nov 16, 2026 |
| Greenwich Wealth Management Llc | Buy | +44,299 | — | 44,299 | $54.05K | Q3 2026 | Nov 16, 2026 |
| Vestmark Advisory Solutions, Inc. | Buy | +38,761 | — | 38,761 | $47.29K | Q3 2026 | Nov 16, 2026 |
| Susquehanna International Group, Llp | Buy | +27,502 | — | 27,502 | $33.55K | Q3 2026 | Nov 16, 2026 |
| Goldman Sachs Group Inc | Buy | +17,603 | +18.8% | 111,323 | $135.81K | Q3 2026 | Nov 16, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -13,197 | -99.2% | 104 | $127.00 | Q3 2026 | Nov 16, 2026 |
| Point72 Asset Management, L.P. | Buy | +11,868 | — | 11,868 | $14.48K | Q3 2026 | Nov 16, 2026 |
| Engineers Gate Manager Lp | Sell | -10,334 | -30.7% | 23,357 | $28.50K | Q3 2026 | Nov 16, 2026 |
| Wells Fargo & Company/Mn | Buy | +9,721 | +298.2% | 12,981 | $15.84K | Q3 2026 | Nov 16, 2026 |
| Royal Bank Of Canada | Buy | +3,979 | +93.6% | 8,231 | $10.00K | Q3 2026 | Nov 16, 2026 |
| Toronto Dominion Bank | Buy | +606 | — | 606 | $739.00 | Q3 2026 | Nov 16, 2026 |
| Zacks Investment Management | Sell | -353 | -1.3% | 26,082 | $31.82K | Q3 2026 | Nov 16, 2026 |
| Strategic Financial Concepts, Llc | Buy | +10 | — | 10 | $13.00 | Q3 2026 | Nov 16, 2026 |
| Marshall Wace, Llp | Buy | +2,279,039 | — | 2,279,039 | $2.78M | Q3 2026 | Nov 13, 2026 |
| Vanguard Capital Management Llc | Buy | +948,795 | +26.0% | 4,599,357 | $5.61M | Q3 2026 | Nov 13, 2026 |
| Quadrature Capital Ltd | Buy | +616,188 | +238.0% | 875,116 | $1.07M | Q3 2026 | Nov 13, 2026 |
| Hrt Financial Lp | Buy | +351,052 | +250.0% | 491,484 | $599.00 | Q3 2026 | Nov 13, 2026 |
Frequently asked questions about INO activity
Which institutional owners are buying INO?
Institutional owners buying INO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in INO activity?
"Buy" means an investor increased their reported position in INO compared to the prior reporting period. This reflects growing exposure to INOVIO PHARMACEUTICALS INC (INO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in INO increasing?
Institutional interest in INO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related INO Institutional Insights
- INO Overview
- INO 13F Institutional Holders
- INO Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- INO Insider Trading & SEC Form 4 Activity
- INO Articles
- Top Institutional Investor Stock Rankings